4//SEC Filing
Bensen Daniel 4
Accession 0001193125-25-284935
CIK 0001863127other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 7:03 PM ET
Size
10.2 KB
Accession
0001193125-25-284935
Insider Transaction Report
Form 4
Bensen Daniel
Chief Discovery Officer
Transactions
- Sale
Common Stock
2025-11-13$16.00/sh−1,111$17,780→ 426,870 total - Sale
Common Stock
2025-11-14$16.02/sh−110,228$1,765,489→ 316,642 total - Sale
Common Stock
2025-11-17$16.11/sh−18,572$299,191→ 298,070 total - Sale
Common Stock
2025-11-17$17.07/sh−1,500$25,607→ 296,570 total
Footnotes (5)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.02. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F3]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.13. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F4]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $17.00. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F5]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.06 to $17.09. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Documents
Issuer
Tyra Biosciences, Inc.
CIK 0001863127
Entity typeother
Related Parties
1- filerCIK 0001880946
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 7:03 PM ET
- Size
- 10.2 KB